HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hazard in ductal stenting: helicoid open cell stents.

Abstract
Stent implantation in the arterial duct has achieved great acceptance as an alternative to an aortopulmonary shunt procedure. Despite challenging, also tortuous arterial ducts as in ToF and pulmonary atresia with VSD can be addressed, since flexible open cell coronary stents are available. We describe two patients with ToF and Ebstein's anomaly where a special helicoid open cell stent was implanted to cross a highly stenotic sigmoid arterial duct. In both patients, the stent design resulted in extremely kinked stent segments with minor or absent flow through the stent lumen. While in one patient early ToF-repair was required, in the other recrossing and restenting with another open cell but not helicoid tubular design type of stent allowed adequate pulmonary perfusion. Although mimicking of the natural course even in tortuous ducts is not mandatory, kinking of the stent is likely to occur in these types of arterial ducts. On the basis of our experience, we can not recommend helicoid manufactured stents in the scenario of ductal stenting, especially in congenital heart disease with completely duct dependent pulmonary circulation.
AuthorsErwin Kitzmüller, Doris Luckner, Ina Michel-Behnke
JournalCatheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (Catheter Cardiovasc Interv) Vol. 74 Issue 6 Pg. 901-4 (Nov 15 2009) ISSN: 1522-726X [Electronic] United States
PMID19496141 (Publication Type: Case Reports, Journal Article)
CopyrightCopyright 2009 Wiley-Liss, Inc.
Topics
  • Abnormalities, Multiple
  • Catheterization (adverse effects, instrumentation)
  • Constriction, Pathologic
  • Ductus Arteriosus, Patent (diagnostic imaging, therapy)
  • Ebstein Anomaly (diagnostic imaging, therapy)
  • Humans
  • Infant
  • Infant, Newborn
  • Male
  • Prosthesis Design
  • Radiography
  • Stents (adverse effects)
  • Tetralogy of Fallot (diagnostic imaging, therapy)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: